MRKR (Marker Therapeutics, Inc. Common Stock) Stock Analysis - Insider Trades
Marker Therapeutics, Inc. Common Stock (MRKR) is a publicly traded Healthcare sector company. As of May 21, 2026, MRKR trades at $1.41 with a market cap of $23.18M and a P/E ratio of -2.33. MRKR moved +2.16% today. Year to date, MRKR is -21.23%; over the trailing twelve months it is +23.68%. Its 52-week range spans $0.81 to $5.95. Analyst consensus is buy with an average price target of $9.00. Rallies surfaces MRKR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading MRKR stock inside the company?
Recent MRKR insider activity includes ELMS STEVE bought 11.09K, New Enterprise Associates 16, L.P. bought 554.25K, Wasserman Frederick Gerald bought 10.00K, Eansor Norman David bought 14.29K, and Walker Paul Edward bought 5.71M. Rallies tracks insider transaction dates, shares, prices, and estimated values.
MRKR Key Metrics
Key financial metrics for MRKR
Metric
Value
Price
$1.41
Market Cap
$23.18M
P/E Ratio
-2.33
EPS
$-0.61
Dividend Yield
0.00%
52-Week High
$5.95
52-Week Low
$0.81
Volume
3.84K
Avg Volume
0
Revenue (TTM)
$3.95M
Net Income
$-10.90M
Gross Margin
0.00%
Recent MRKR Insider Trades
ELMS STEVE bought 11.09K (~$35.47K) on Dec 23, 2024.
New Enterprise Associates 16, L.P. bought 554.25K (~$1.77M) on Dec 23, 2024.
Wasserman Frederick Gerald bought 10.00K (~$24.10K) on May 18, 2021.
Eansor Norman David bought 14.29K (~$249.99K) on Mar 16, 2021.
Walker Paul Edward bought 5.71M (~$10.00M) on Mar 16, 2021.
Recent MRKR insider activity includes ELMS STEVE bought 11.09K, New Enterprise Associates 16, L.P. bought 554.25K, Wasserman Frederick Gerald bought 10.00K, Eansor Norman David bought 14.29K, and Walker Paul Edward bought 5.71M. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for MRKR?
Yes. Rallies tracks MRKR insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is MRKR research on Rallies investment advice?
No. Rallies provides research, data, and educational context for MRKR. It does not provide personalized investment advice.